Skip to content

Codes for disabilities, serious illnesses, learning difficulties and neurodevelopmental disorders

In the following table you can find the list with the disability codes used by the NKUA for classifying students admitted to the university benefiting from the regulation providing 5% (formerly 3%) additional quota for persons with disabilities; on the right column you can find the current corresponding codes used by the Greek Ministry of Education and Religious Affairs. No data in this table will be deleted or modified, whereas new data may be added.
Unfortunately, the Greek Ministry of Education and Religious Affairs changes the list with the disability codes by adding or deleting disabilities and diseases every year.
NKUA CodeShort descriptionGreek Ministry of Education and Religious Affairs Code for the acad. year 2021-2022
01Blind01 Blind
02Low visual acuity02 Low visual acuity (with a disability degree of at least 80%)
03Deaf03 Deaf
04Deaf-mute04 Deaf-mute
05Mediterranean anemia/
Thalassemia major
05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
06Sickle cell anemia05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
07Micro-sickle cell anemia05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
08Hydrocephalus06 Persons with congenital hydrocephalus with permanent artificial shunting of cerebrospinal fluid accompanied by other defects such as arachnoid cyst with epileptic seizure symptoms
09Duchenne muscular dystrophy07 Persons suffering from Duchenne muscular dystrophy
10Brainstem severe vascular malformation08 Persons suffering from brainstem severe vascular malformation
11Malignant neoplasms09 Persons who have suffered in the past or suffer in the present from malignant neoplasms (leukemias, lymphomas, solid tumors)
12Bund Chiari syndrome10 Persons suffering from Bund Chiari syndrome
13Fabry disease11 Persons suffering from Fabry disease
14Cystic fibrosis (of the pancreas or the lungs)12 Persons suffering from severe cystic fibrosis of the pancreas or the lungs
15Multiple sclerosis13 Persons suffering from multiple sclerosis
16Myasthenia gravis14 Persons suffering from myasthenia gravis for which they receive pharmaceutical treatment
17Persons suffering from kidney failure receiving hemodialysis or peritoneal dialysis15 Persons suffering from chronic kidney failure treated with hemodialysis or peritoneal dialysis
18Congenital bleeding diathesis – hemophilias16 Persons suffering from congenital bleeding diathesis – hemophilia treated with coagulation factors
19Bone Marrow Transplantation17 Persons submitted to bone Marrow transplantation
20Cornea transplantation18 Persons submitted to cornea transplantation
21Heart transplantation19 Persons submitted to heart transplantation
22Liver transplantation20 Persons submitted to liver transplantation
23Lungs transplantation21 Persons submitted to lungs transplantation
24Kidney transplantation22 Persons submitted to kidney transplantation
25Pancreas transplantation23 Persons submitted to pancreas transplantation
26Small bowel transplantation24 Persons submitted to small bowel transplantation
27Juvenile diabetes (Type 1 diabetes)25 Persons suffering from insulin-dependent type 1 diabetes (juvenile diabetes)
28Evans syndrome26 Persons suffering from Evans syndrome
29Persons suffering from Mediterranean anemia/
Thalassemia major undergoing multiple blood transfusions
05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/ Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
30Motor disabilities27 Persons with motor disabilities deemed disabled with a degree of disability of at least 67%
31Phenylketonuria28 Persons suffering from phenylketonuria
32Persons suffering from congenital thrombophilia receiving lifelong anticoagulation treatment29 Persons suffering from congenital thrombophilia receiving lifelong anticoagulation treatment
33Arrhythmogenic right ventricular cardiomyopathy with implanted cardioverter-defibrillator30 Persons with arrhythmogenic right ventricular cardiomyopathy with implanted cardioverter-defibrillator
34Gaucher disease31 Persons with Gaucher disease
35Complex congenital heart diseases32 Persons suffering from complex congenital heart diseases operated or not
36Single ventricle
37Truncus arteriosus communis
38Myocardial disease resulting in permanent malfunction
39Hypertrophic cardiomyopathy33 Persons suffering from hypertrophic cardiomyopathy
40Pulmonary arterial hypertension34 Persons suffering from pulmonary arterial hypertension diagnosed by right heart catheterization
41Severe pulmonary fibrosis35 Persons suffering from severe pulmonary fibrosis of any cause
42Brugada syndrome-
43Idiopathic ventricular tachycardia36 Persons suffering from idiopathic ventricular tachycardia with implanted defibrillator
44Glycogen storage diseases37 Persons suffering from glycogen storage diseases
45Liver cirrhosis with portal hypertension38 Persons suffering from liver cirrhosis with attested portal hypertension
46Portal hypertension due to portal vein hypoplasia39 Persons suffering from portal hypertension due to portal vein hypoplasia
47Crohn’s disease40 Persons suffering from Crohn’s disease attested after biopsy
48Wilson’s disease41 Persons suffering from Wilson’s disease
49Multiple neurofibromatosis (Recklinghausen)42 Persons suffering from multiple neurofibromatosis syndrome (Recklinghausen) recurring systematically
50Multiple myeloma43 Persons suffering from multiple myeloma
51Sarcoidosis44 Persons suffering from sarcoidosis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment related to this disease in the present due to lung or/and central nervous system infection
52Autoimmune hepatitis45 Persons suffering from autoimmune hepatitis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment related to this disease in the present.
53Glomerulonephritis79 Persons suffering from glomerulonephritis receiving major immunosuppressive therapy (azathioprine, mycophenolic acid, cyclophosphamide, calcineurin inhibitors,
rituximab) or high dosage of corticosteroids (Prednisone more than 0,5 mg/kg of body weight)
54Total laryngectomy46 Persons submitted to total laryngectomy
55Brain craniopharyngioma47 Persons suffering from brain craniopharyngioma
56Systemic lupus erythematosus48 Persons suffering from systemic lupus erythematosus receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment in the present related to this disease due to kidneys or/and central nervous system or/and serous membranes or/and blood infection
57Systemic scleroderma49 Persons suffering from systemic scleroderma with diffuse skin infection
58Short bowel syndrome75 Persons suffering from short bowel syndrome
59Ulcerative colitis under pharmaceutical treatment50 Persons suffering from ulcerative colitis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment related to this disease in the present
60Ulcerative colitis submitted to (procto)colectomy51 Persons suffering from ulcerative colitis submitted to total proctocolectomy and permanent ileostomy or subtotal colectomy with ileocolic anastomosis or created ileoanal pouch
61Autoimmune thrombocytopenia52 Persons suffering from autoimmune hemolytic anemia or autoimmune thrombocytopenia receiving major immunosuppressive therapy
62Juvenile idiopathic arthritis54 Persons suffering from continuously active juvenile idiopathic arthritis after the age of 14 years despite the biological treatment
63Acquired immunodeficiency syndrome (AIDS)55 Persons suffering from acquired immunodeficiency syndrome (AIDS) under antiretroviral therapy
64Paroxysmal nocturnal hemoglobinuria56 Persons suffering from paroxysmal nocturnal hemoglobinuria in need of chronic regular transfusions
65Idiopathic thrombocytopenic purpura-
66Autoimmune hemolytic anemia52 Persons suffering from autoimmune hemolytic anemia or autoimmune thrombocytopenia receiving major immunosuppressive therapy
67Klippel-Feil syndrome53 Persons suffering from the Klippel-Feil syndrome
68Rare syndromes – diseases57 Persons suffering from various rare congenital, hereditary or acquired syndromes – diseases characterized by severe clinical manifestations deemed disabled with a degree of disability of at least 67%; to be examined on case-by-case basis
69Klipper Trenaunay-Weber Syndrome58 Persons suffering from Klipper Trenaunay-Weber syndrome
70Mucopolysaccharidoses Type 659 Persons suffering from mucopolysaccharidoses Type 6
71Dermatomyositis60 Persons suffering from dermatomyositis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment in the present related to this disease
72Muckle Wells syndrome61 Persons suffering from Muckle Wells syndrome (symptomatic disease with conventional clinical picture with a confirmed diagnosis by a pediatrician with experience in rheumatic diseases, genetic confirmatory testing for NALP3 cryopyrin mutation desired but not mandatory, since mutations are not attested in every patient, treatment with biological agents such as Interleukin IL-1 inhibitors)
73Hereditary angioedema62 Persons suffering from laboratory confirmed severe hereditary angioedema
74Benign pontine tumor 63 Persons suffering from benign pontine tumor with a degree of disability of at least 67%
75Aneurysm rupture with bleeding and hydrocephalus64 Persons suffering from aneurysm rupture with bleeding and hydrocephalus with a degree of disability of at least 67%
76Congenital hemolytic anemia or Diamond Blackfan anemia05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/ Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
77Dyserythropoietic anemia65 Persons suffering from dyserythropoietic anemia confirmed with bone marrow biopsy and long-term need for transfusions
78Tuberous sclerosis or Bourneville disease66 Persons suffering from tuberous sclerosis or Bourneville disease (phakomatosis of the central nervous system with various complications of the central nervous system, such as abnormal gait, difficulty with fine motor skills, concentration problems, fatigue etc)
79Marfan syndrome67 Persons suffering from Marfan syndrome
80Crouzon syndrome or craniofacial dysostosis68 Persons suffering from Crouzon syndrome or craniofacial dysostosis
81Melorheostosis69 Persons suffering from melorheostosis with 80% degree of disability
82Ichthyosiform erythroderma70 Persons suffering from ichthyosiform erythroderma with 67% degree of disability
83Pharmacoresistant epilepsy71 Persons suffering from pharmacoresistant epilepsy with 67% degree of disability
84Systemic mastocytosis72 Persons suffering from systemic mastocytosis confirmed with bone marrow biopsy and the level of tryptase in the blood
85Kawasaki disease73 Persons suffering from Kawasaki disease along with coronary artery disease or giant coronary artery aneurysms
86Lamellar ichthyosis74 Persons suffering from lamellar ichthyosis
87Idiopathic nephrotic syndrome76 Persons suffering from idiopathic nephrotic syndrome receiving major immunosuppressive therapy at least one (1) year after the diagnosis (prednisone dosage of at least >0,5 mg/kg in combination with cyclophosphamide, calcineurin inhibitors, mycophenolic acid or biological agents such as rituximab)
88Vasculitis/Angiitis77 Persons suffering from vasculitis/angiitis receiving biological therapy or major immunosuppressive therapy or having received major immunosuppressive therapy in the past following a different treatment in the present related to this disease
89Severe congenital immunodeficiencies78 Persons suffering from severe congenital immunodeficiencies under immunoglobulin replacement therapy
90Acquired Immunodeficiency Syndrome (Stage C)80 Persons suffering from acquired immunodeficiency syndrome (HIV Infection Stage C) under antiretroviral therapy on gravity level 3, that is with opportunistic infections: Pneumonia caused by Pneumocystis jiroveci, cerebral toxoplasmosis, fungal esophagitis, cryptosporidiosis, microsporidiosis, tuberculosis, infiltrative form of cervical cancer, Kaposi's sarcoma, lymphomas, neurocognitive disorders, pervasive mycobacterial disease, avium complex, cryptococcal meningitis, progressive multifocal leukoencephalopathy, wasting syndrome
91Disability degree certified by a Disability Certification Centre (KEPA)-
92Learning disabilities [NKUA code]-
93ADHD (Attention-deficit/hyperactivity disorder) [NKUA code]-
94Pervasive neurodevelopmental disorders [NKUA code]-
95Psychological disorders [NKUA code]-